Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer

Zhenxin Lin, Diane M. Simeone, Michelle A. Anderson, Randall E. Brand, Xiaolei Xie, Kerby A. Shedden, MacK T. Ruffin, David M. Lubman

Research output: Contribution to journalArticlepeer-review

70 Scopus citations


A mass spectrometric method was developed to elucidate the N-glycan structures of serum glycoproteins and utilize fucosylated glycans as potential markers for pancreatic cancer. This assay was applied to haptoglobin in human serum where N-glycans derived from the serum of 16 pancreatic cancer patients were compared with those from 15 individuals with benign conditions (5 normals, 5 chronic pancreatitis, and 5 type II diabetes). This assay used only 10 μL of serum where haptoglobin was extracted using a monoclonal antibody and quantitative permethylation was performed on desialylated N-glycans followed by MALDI-QIT-TOF MS analysis. Eight desialylated N-glycan structures of haptoglobin were identified where a bifucosylated triantennary structure was reported for the first time in pancreatic cancer samples. Both core and antennary fucosylation were elevated in pancreatic cancer samples compared to samples from benign conditions. Fucosylation degree indices were calculated and show a significant difference between pancreatic cancer patients of all stages and the benign conditions analyzed. This study demonstrates that a serum assay based on haptoglobin fucosylation patterns using mass spectrometric analysis may serve as a novel method for the diagnosis of pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)2602-2611
Number of pages10
JournalJournal of Proteome Research
Issue number5
StatePublished - May 6 2011

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • General Chemistry


Dive into the research topics of 'Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer'. Together they form a unique fingerprint.

Cite this